Phase 2 Langerhans Cell Histiocytosis (LCH) Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Mirdametinib in Histiocytic Disorders

Histiocytic DisordersRosai-Dorfman Disease (RDD)Langerhans Cell Histiocytosis (LCH)+1 more

Children's Hospital Medical Center, Cincinnati40 enrolled1 locationNCT06153173

Recruiting

Phase 2

Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children

Langerhans Cell Histiocytosis (LCH)

West China Second University Hospital20 enrolled1 locationNCT07022834